Trademark: 85110019
Word
RAFLIFTO
Status
Dead
Status Code
710
Status Date
Friday, January 19, 2018
Serial Number
85110019
Registration Number
3976965
Registration Date
Tuesday, June 14, 2011
Mark Type
4000
Filing Date
Wednesday, August 18, 2010
Published for Opposition
Tuesday, March 29, 2011
Cancellation Date
Friday, January 19, 2018

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Jan 19, 2018
Cancelled Sec. 8 (6-Yr)
Jun 14, 2016
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 23, 2015
Teas Change Of Correspondence Received
Mar 25, 2013
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 25, 2013
Teas Change Of Owner Address Received
Jun 14, 2011
Registered-Principal Register
Mar 29, 2011
Official Gazette Publication Confirmation E-Mailed
Mar 29, 2011
Published For Opposition
Feb 24, 2011
Law Office Publication Review Completed
Feb 24, 2011
Assigned To Lie
Jan 29, 2011
Approved For Pub - Principal Register
Jan 19, 2011
Teas/Email Correspondence Entered
Jan 19, 2011
Correspondence Received In Law Office
Jan 19, 2011
Teas Response To Suspension Inquiry Received
Nov 7, 2010
Notification Of Letter Of Suspension E-Mailed
Nov 7, 2010
Letter Of Suspension E-Mailed
Nov 7, 2010
Suspension Letter Written
Nov 7, 2010
Assigned To Examiner
Aug 23, 2010
New Application Office Supplied Data Entered In Tram
Aug 21, 2010
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24